Status:
RECRUITING
Psychosomatic Intervention in Fibromyalgia.
Lead Sponsor:
University of Florence
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fibromyalgia is a widespread musculoskeletal pain syndrome. It is characterized by physical manifestations which are also the expression of a psychological distress as well as specific illness attitud...
Detailed Description
Fibromyalgia (FM) is a widespread musculoskeletal pain syndrome characterized by chronic widespread pain, unrefreshing sleep, physical exhaustion, and cognitive difficulties. It occurs in all populati...
Eligibility Criteria
Inclusion
- able and interested in participating to the research, as proved by signed Informed consent;
- a diagnosis of FM according to the Italian Society for Rheumatology clinical practice guidelines (Ariani et al., 2021)
- age higher than 18 years
Exclusion
- co-occurrence of psychiatric disorder(s) according to the Diagnostic and Statistical Manual of mental disorders, 5th edition (American Psychiatric Association, 2013) as diagnosed via the Mini-International Neuropsychiatric Interview;
- currently under psychotherapy;
- pharmacological modifications during the period of the trial;
- undergoing non pharmacological interventions during the period of the trial
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06135753
Start Date
November 1 2023
End Date
December 30 2026
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumtoi Unit, Academic Hospital Careggi
Florence, Italia/firenze, Italy, 50135